Literature DB >> 10767101

Ultrastructural localisation of ATP-gated P2X2 receptor immunoreactivity in the rat hypothalamo-neurohypophysial system.

A Loesch1, S Miah, G Burnstock.   

Abstract

The distribution of the P2X(2) subtype of the purine receptor associated with the extracellular signalling activities of ATP was studied in the rat hypothalamo-neurohypophysial system at the electron microscope level. Receptors were labelled with ExtrAvidin-horseradish peroxidase preembedding immunocytochemistry using a polyclonal antibody against a fragment of an intracellular domain of the receptor. Immunoreactivity to P2X(2) receptors was localised in: (i) paraventricular and supraoptic nuclei-in subpopulations of endocrine neurones, neurosecretory and non-neurosecretory axons and dendrites; and (ii) the neurohypophysis-in pituicytes and subpopulation of neurosecretory axons. In both the hypothalamic nuclei examined, labelled asymmetric axo-dendritic synapses were commonly observed. These synapses involved either P2X(2)-labelled axon terminals (synaptic buttons) and unlabelled dendrites or labelled dendrites and unlabelled axon terminals. Axo-somatic synapses established by P2X(2)-positive axons on P2X(2)-positive endocrine cell bodies as well as on P2X(2)-negative somata were also observed. The functional significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10767101     DOI: 10.1023/a:1007009222518

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  13 in total

1.  Adenosine inhibition via A(1) receptor of N-type Ca(2+) current and peptide release from isolated neurohypophysial terminals of the rat.

Authors:  Gang Wang; Govindan Dayanithi; Edward E Custer; José R Lemos
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

2.  P2X receptors are differentially expressed on vasopressin- and oxytocin-containing neurons in the supraoptic and paraventricular nuclei of rat hypothalamus.

Authors:  Wei Guo; Jihu Sun; Xiaohui Xu; Geoffrey Bunstock; Cheng He; Zhenghua Xiang
Journal:  Histochem Cell Biol       Date:  2008-09-12       Impact factor: 4.304

3.  Adenosine trisphosphate appears to act via different receptors in terminals versus somata of the hypothalamic neurohypophysial system.

Authors:  T K Knott; N Hussy; A E Cuadra; R H Lee; S Ortiz-Miranda; E E Custer; J R Lemos
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

Review 4.  Purinergic signaling pathways in endocrine system.

Authors:  Ivana Bjelobaba; Marija M Janjic; Stanko S Stojilkovic
Journal:  Auton Neurosci       Date:  2015-04-25       Impact factor: 3.145

5.  ATP elicits inward currents in isolated vasopressinergic neurohypophysial terminals via P2X2 and P2X3 receptors.

Authors:  Thomas K Knott; Cristina Velázquez-Marrero; José R Lemos
Journal:  Pflugers Arch       Date:  2005-06-30       Impact factor: 3.657

6.  P2X2 and P2X3 purinoceptors in the rat enteric nervous system.

Authors:  Zhenghua Xiang; Geoffrey Burnstock
Journal:  Histochem Cell Biol       Date:  2004-02-06       Impact factor: 4.304

7.  P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes.

Authors:  Ulyana Lalo; Yuri Pankratov; Sven P Wichert; Moritz J Rossner; R Alan North; Frank Kirchhoff; Alexei Verkhratsky
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

Review 8.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

9.  Astrocyte-mediated distributed plasticity at hypothalamic glutamate synapses.

Authors:  Grant R J Gordon; Karl J Iremonger; Srinivas Kantevari; Graham C R Ellis-Davies; Brian A MacVicar; Jaideep S Bains
Journal:  Neuron       Date:  2009-11-12       Impact factor: 17.173

Review 10.  Signaling by purinergic receptors and channels in the pituitary gland.

Authors:  Stanko S Stojilkovic; Mu-Lan He; Taka-aki Koshimizu; Ales Balik; Hana Zemkova
Journal:  Mol Cell Endocrinol       Date:  2009-05-23       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.